Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines

被引:0
|
作者
Kubo, K [1 ]
Matsuzaki, Y [1 ]
Kato, A [1 ]
Terai, S [1 ]
Okita, K [1 ]
机构
[1] Yamaguchi Univ, Sch Med, Dept Internal Med 1, Ube, Yamaguchi 7558505, Japan
关键词
vesnarinone; antitumor effect; hepatocellular carcinoma; apoptosis; nucleotide synthesis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vesnarinone, a quinolinone derivative, induces apoptosis and differentiation in some tumor cell lines. We examined the antitumor effect of vesnarinone on three human hepatocellular carcinoma (HCC) cell lines. Vesnarinone suppressed the proliferation of all three HCC cell lines, but did not induce apoptosis and differentiation. Vesnarinone has also been reported to inhibit both nucleoside and nucleobase transport. Concomitant administration of vesnarinone and a de novo nucleotide synthesis inhibitor potentiated the growth-inhibitory effect of vesnarinone on HCC cells. Vesnarinone may be useful as a new biochemical modulator of anticancer agents.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [31] Antitumor Effects of Soluble TRAIL in Human Hepatocellular Carcinoma
    何松青
    陈彦
    陈孝平
    赵永忠
    王海平
    张万广
    王少发
    华中科技大学学报(医学英德文版), 2005, (01) : 51 - 54
  • [32] Antitumor effects of soluble TRAIL in human hepatocellular carcinoma
    He Songqing
    Chen Yan
    Chen Xiaoping
    Zhao Yongzhong
    Wang Haiping
    Zhang Wanguang
    Wang Shaofa
    Current Medical Science, 2005, 25 (1) : 51 - 54
  • [33] Effects of quinolinone derivative, vesnarinone, in combination with irradiation on human lung cancer cell lines
    Fujita, M
    Tsuchida, T
    Fujita, T
    Higashino, K
    ONCOLOGY REPORTS, 1999, 6 (02) : 353 - 357
  • [34] Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines
    Pandha, Hardev
    Birchall, Lindsay
    Meyer, Brendan
    Wilson, Natalie
    Relph, Kate
    Anderson, Christopher
    Harrington, Kevin
    JOURNAL OF UROLOGY, 2006, 176 (05): : 2255 - 2261
  • [35] Antitumor effect of gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo
    Hara, F
    Aoe, M
    Doihara, H
    Taira, N
    Shien, T
    Takahashi, H
    Yoshitomi, S
    Tsukuda, K
    Toyooka, S
    Ohta, T
    Shimizu, N
    CANCER LETTERS, 2005, 226 (01) : 37 - 47
  • [36] FIBRONECTIN IN HUMAN HEPATOCELLULAR-CARCINOMA (HCC) AND HCC CELL-LINES
    TSUMAGARI, J
    ACTA PATHOLOGICA JAPONICA, 1987, 37 (03): : 413 - 423
  • [37] THE EXPRESSION OF FAS ANTIGEN IN HUMAN HEPATOCELLULAR-CARCINOMA CELL-LINES
    YANO, H
    IEMURA, A
    FUKUDA, K
    HARAMAKI, M
    MOMOSAKI, S
    OGASAWARA, S
    INOUE, M
    KOJIRO, M
    LABORATORY INVESTIGATION, 1995, 72 (01) : A134 - A134
  • [38] CHARACTERIZATION OF TUMOUR CELL LINES GENERATED FROM PRIMARY HUMAN HEPATOCELLULAR CARCINOMA
    Cattaneo, Alessandra
    Colombo, Federico
    Mazzucchelli, Silvia
    Baldan, Francesca
    Foglieni, Barbara
    Rossi, Giorgio
    Mazzaferro, Vincenzo
    Prati, Daniele
    Porretti, Laura
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 429 - 429
  • [39] Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines
    Keck, CL
    Zimonjic, DB
    Yuan, BZ
    Thorgeirsson, SS
    Popescu, NC
    CANCER GENETICS AND CYTOGENETICS, 1999, 111 (01) : 37 - 44
  • [40] CHARACTERIZATION OF CELL-LINES ESTABLISHED FROM HUMAN HEPATOCELLULAR-CARCINOMA
    PARK, JG
    LEE, JH
    KANG, MS
    PARK, KJ
    JEON, YM
    LEE, HJ
    KWON, HS
    PARK, HS
    YEO, KS
    LEE, KU
    KIM, ST
    CHUNG, JK
    HWANG, YJ
    LEE, HS
    KIM, CY
    LEE, YI
    CHEN, TR
    HAY, RJ
    SONG, SY
    KIM, WH
    KIM, CW
    KIM, YI
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (03) : 276 - 282